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ABSTRACT The mechanism of leakage induced by surface active peptides is not yet fully understood. To gain insight into
the molecular events underlying this process, the leakage induced by the peptide pardaxin from phosphatidylcholine/
phosphatidylserine/cholesterol large unilamellar vesicles was studied by monitoring the rate and extent of dye release and by
theoretical modeling. The leakage occurred by an all-or-none mechanism: vesicles either leaked or retained all of their
contents. We further developed a mathematical model that includes the assumption that certain peptides become incorpo-
rated into the vesicle bilayer and aggregate to form a pore. The current experimental results can be explained by the model
only if the surface aggregation of the peptide is reversible. Considering this reversibility, the model can explain the final
extents of calcein leakage for lipid/peptide ratios of >2000:1 to 25:1 by assuming that only a fraction of the bound peptide
forms pores consisting of M = 6 + 3 peptides. Interestingly, less leakage occurred at 430C than at 300C, although peptide
partitioning into the bilayer was enhanced upon elevation of the temperature. We deduced that the increased leakage at 300C
was due to an increase in the extent of reversible surface aggregation at the lower temperature. Experiments employing
fluorescein-labeled pardaxin demonstrated reversible aggregation of the peptide in suspension and within the membrane,
and exchange of the peptide between liposomes. In summary, our experimental and theoretical results support reversible
surface aggregation as the mechanism of pore formation by pardaxin.
INTRODUCTION
Pore formation and leakage occur in cells upon addition of
toxic polypeptides to the medium (Primor et al., 1978;
Harshman et al., 1989; Wu and Aronson, 1992; Gazit and
Shai, 1993; Ghosh et al., 1993; Shai, 1994) or during
interactions of certain viruses with liposomes and cells
(Spruce et al., 1989; Cheetham et al., 1990; White, 1992). A
better understanding of pore formation and leakage may be
helpful in optimizing drug delivery via liposomes, because
the leakage induced by serum components may occur in
certain cases by pore formation. Studies on the kinetics of
leakage and channel formation by peptides from various
sources have been reported (Lear et al., 1988; Schwarz and
Beschiaschvili, 1989; Rafalski et al., 1991; Martin et al.,
1991; Duzgunes and Shavnin, 1992; Epand et al., 1992).
Leakage from liposomes due to pore formation by pep-
tides can be characterized by the following (Parente et al.,
1990): 1) The extent of leakage increases with time until it
reaches its final extent, which is dependent on the lipid!
peptide ratio. 2) The leakage of vesicle contents follows an
all-or-none mechanism (Weinstein et al., 1981), i.e., when
the entrapped molecules are small enough to be released,
some of the vesicles release all of their contents, whereas
others retain all their contents. The leakage induced by
several peptides, among them the model peptide GALA
(Parente et al., 1990), the fusion peptide of human immu-
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nodeficiency virus (HIV) (Nieva et al., 1994), and the
amphipathic peptide pardaxin (Rapaport et al., 1994), ful-
fills these requirements and therefore may occur via pore
formation.
The mathematical model of pore formation includes the
assumption that after a rapid stage of peptide binding to the
vesicle membranes, surface aggregation of peptide occurs.
When the structure and conformation of the peptide used are
appropriate, the aggregates that have reached a critical size
(i.e., include M or more peptides) will form a pore. If
surface aggregation of the peptide is irreversible, then ves-
icles that include M or more bound peptides will eventually
leak all of their encapsulated contents (criterion 2), whereas
the other vesicles will not leak at all. The kinetics of leakage
is dictated by the kinetics of surface aggregation, because
once a pore has formed, the leakage of all the contents
occurs within less than 1 s (Lewis and McConnel, 1978;
Parente et al., 1990), thus yielding a finite final extent
(criterion 1). The size of the pore determines the size of
molecules that can leak (criterion 2) and the final extent of
leakage. The model correctly simulated the kinetics of leak-
age and in addition yielded quantitative predictions of the
increase in the final extent of leakage with an increase in the
sizes of the liposomes (Parente et al., 1990).
Pardaxin is an amphipathic 33-residue neurotoxic peptide
with the sequence GFFALIPKIISSPLFKTLLSAVG-
SALSSSGGQE. It was found to interact with various lipid
vesicles and to induce the leakage of entrapped dyes (Laz-
arovici et al., 1986; Shai et al., 1988, 1990, 1991; Rapaport
et al., 1994). Moreover, using fluorescently labeled analogs,
we have shown that pardaxin tends to self-associate in its
membrane-bound state (Rapaport and Shai, 1991, 1992).
The model that includes the assumption of irreversible
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surface aggregation was found to be inappropriate for de-
scribing pardaxin-induced leakage, and therefore, in the
current study, we extended the model by considering re-
versible surface aggregation of the peptide. When surface
aggregation is reversible, only a fraction of the vesicles
containing more than M peptides will include a pore and
leak all of their contents. We experimentally confirmed our
deduction of reversible surface aggregation of pardaxin in
membranes composed of PC/PS/Chol by studying the effect
of temperature on the leakage and by employing fluores-
cently labeled peptide.
MATERIALS AND METHODS
Materials
Egg phosphatidylcholine (PC) and phosphatidylserine (PS) from bovine
spinal cord (sodium salt, grade I) were purchased from Lipid Products
(South Nutfield, England). Cholesterol (extra pure) was purchased from
Merck (Darmstadt, Germany) and was recrystallized twice from ethanol.
N-(7-Nitrobenz-2-oxa-1, 3-diazol-4-yl) (NBD)-fluoride, calcein, and re-
agents for peptide synthesis were obtained from Sigma. N-(Lissamine-
rhodamine B sulfonyl) phosphatidylethanolamine (Rh-PE), N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (NBD-PE), and
5-(and 6)-carboxyfluorescein, succinimidyl ester were purchased from
Molecular Probes (Junction City, OR).
Peptide synthesis, modification, and purification
The peptide pardaxin was synthesized and labeled at its N-terminus as
previously described (Merrifield et al., 1982; Shai et al., 1990; Rapaport
and Shai, 1992). Briefly, resin-bound peptide was treated with trifluoro-
acetic acid to remove the t-butyloxycarbonyl protecting group from its
N-terminal amino group. The peptide was then reacted with either 5- (and
6-) carboxyfluorescein, succinimidyl ester, or NBD-fluoride and finally
cleaved from the resins by HF. The peptides were purified (>95% homo-
geneity) by reverse-phase high-performance liquid chromatography on a
C18 column using a linear gradient that increased from 25% to 80%
acetonitrile in 0.1% trifluoroacetic acid in 40 min. The composition and
mass of the peptide were verified by amino acid analysis and fast atomic
bombardment mass spectrometry, respectively.
Preparation of lipid vesicles
Large unilamellar vesicles (LUVs) were prepared from phospholipids by
extrusion (Hope et al., 1985). Dry lipids were hydrated in buffer and
dispersed by vortexing to produce multilamellar vesicles. The lipid sus-
pension was frozen and thawed five times and extruded three times through
0.4-gm-pore-diameter polycarbonate membranes followed by eight extru-
sions through 0.1-,um-pore-diameter membranes (Poretics Corp., Liver-
more, CA). The lipid concentrations of the liposome suspensions were
determined by phosphorus analysis (Rouser et al., 1966).
Determination of size distribution of vesicles by
dynamic light scattering
Dynamic light scattering of solutions of liposomes was measured. The
system used was based on a correlator made by Brookhaven Instruments BI
2030 and combined with the Contin method for data analysis.
Binding experiments
The degree of peptide association with lipid vesicles was measured by
adding lipid vesicles to 0.1 ,uM NBD-labeled peptides, as previously
described (Rapaport and Shai, 1991). The fluorescence intensity was
measured as a function of the lipid/peptide molar ratio, with the excitation
set at 467 nm (5-nm slit). The fluorescence values were corrected by taking
into account the dilution factor corresponding to the addition of microliter
amounts of liposomes, and by subtracting the corresponding blank (buffer
with the same amounts of vesicles).
Peptide-induced lipid mixing
Lipid mixing of LUVs was measured using a fluorescent probe dilution
assay, based on resonance energy transfer measurements (Struck et al.,
1981). Lipid vesicles containing 0.6 mol% each of NBD-PE (energy donor)
and Rh-PE (energy acceptor) were prepared in 100 mM NaCl, 25 mM
HEPES, at pH 7.3, and a 1:4 mixture of labeled and unlabeled vesicles was
suspended in 400 ,ul of the buffer at room temperature. The increase in
NBD fluorescence at 530 nm, with the excitation wavelength set at 460 nm,
was monitored with a Perkin-Elmer LS-50B spectrofluorometer. The flu-
orescence intensity before the addition of the peptide and the fluorescence
intensity after the addition of Triton X-100 0.25% (v/v) were referred to,
respectively, as 0 and 100% lipid mixing.
Turbidity measurements
Changes in the size distribution and state of aggregation of the vesicles
were monitored by absorbance measurements. Aliquots of peptide stock
solutions were added to l-ml suspensions of 91 ,uM PS LUVs in buffer
composed of 100 mM NaCl and 25 mM HEPES (pH 7.3). The absorbance
at 405 nm was monitored continuously with a Milton Roy spectrometer.
Leakage assay
The fluorescence of calcein (MW = 623) encapsulated in liposomes at a
self-quenching concentration increases when it leaks out of the vesicles
because of its dilution (Allen and Cleland, 1980). Calcein-containing
vesicles composed of PC/PS/cholesterol (4/4/1, w/w/w) were prepared in
60 mM calcein at pH 7.4 (10 mM HEPES). To remove unencapsulated dye,
the vesicles were passed through a Sephadex G-75 column and eluted with
150 mM NaCl and 10 mM HEPES (pH 7.4). The increase in calcein
fluorescence at 520 nm, with the excitation wavelength set at 490 nm, was
monitored with a Perkin-Elmer LS-50B spectrofluorometer. The contribu-
tion of light scattering to the spectrum was minimized by exciting the
sample with vertically polarized light and measuring horizontally polarized
emitted light. The fluorescence of the liposomes alone or after the addition
of Triton X-100 (final concentration, 0.5% v/v) corresponds to 0 or 100%
leakage, respectively. Thus, the percentage of fluorescence recovery is
defined as
Ft = [(It - Io)/(Im. - I.)] X 100,
where I. is the initial fluorescence, It is the fluorescence observed at time
t after adding the peptide, and I.ax is the fluorescence after the addition of
Triton.
Surface aggregation
Aggregation of the fluorescein-labeled peptide results in close proximity of
the probes on different molecules, and thus their fluorescence is self-
quenched. Therefore, changes in the fluorescence intensity of fluorescein-
labeled pardaxin were measured in the presence of various concentrations
of PC/PS/Chol vesicles and native peptide. The fluorescence intensity was
measured at 525 nm (5-nm slit) with the excitation set at 480 nm (5-nm
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slit), on a Perkin-Elmer LS-50B spectrofluorometer. The contribution of
light scattering to the spectrum was minimized by exciting the sample with
vertically polarized light and measuring horizontally polarized emitted
light, and by placing a cutoff filter of 515 nm between the sample and the
emission detector.
Theoretical analysis of leakage due to pore
formation
The model assumes that 1) the peptides bind and become incorporated into
the bilayer of the vesicles and 2) peptide aggregation occurs within the
membranes. When an aggregate within a membrane has reached a critical
size, i.e., it consists ofM peptides, a channel or pore is created within the
membrane, and leakage of encapsulated molecules can occur. The size of
the pore dictates the upper bound on the size (and shape) of molecules that
can leak. The size of the pore depends on the number of peptides forming
it.
As in a previous study (Parente et al., 1990), we assume that the process
of peptide incorporation into the vesicle membranes is rapid and that once
a pore has been formed in a vesicle all of its contents will leak rather
quickly. Thus, the rate of leakage is assumed to be limited by the rate of
formation of aggregates consisting ofM or more peptides in the membrane.
The kinetics of irreversible aggregation was first investigated by Smolu-
chowski (1917) and later extended to reversible aggregation by Blatz and
Tobolsky (1945). The general scheme as treated by Bentz and Nir (1981)
and Nir et al. (1983) is
Cl,
XI + X1 X2
D,,
(1)
C,'
Xi +X ->X+j,
Dij
where Xi are molar concentrations of aggregates of order i. Here we have
used the same scheme, but in our case Xi denotes surface concentrations.
Previous treatments of the pore model (Parente et al., 1990; Fattal et al.,
1994; Nieva et al., 1994) ignored the possibility of aggregate dissociation,
setting Dii = 0. Here, reversibility of surface aggregation of pardaxin has
been considered. To facilitate the computational procedure and to avoid the
use of many parameters, we have employed the same simplifications made
by Smoluchowski (1917) and by Blatz and Tobolsky (1945), i.e., that Ci,
= C and Dii = D for all i and j. It has been shown (Peled et al., 1995) that
with these assumptions the analytic solution of Blatz and Tobolsky (1945)
yields results that are essentially similar to the numeric solutions (Bentz
and Nir, 1981; Nir et al., 1983).
The fraction of encapsulated material that has leaked at time t is denoted
by L(t). Because of the dependence of the encapsulated volume on the third
power of the inner diameter, a small fraction of large vesicles can contrib-
ute significantly to L(t). Therefore, in the current treatment, we considered
the vesicles to consist of j = 1, . . . S size classes. The distribution of
vesicles according to their diameters was determined by dynamic light
scattering. In practice, we set S = 15 and we denote the fraction of
encapsulated volume in vesicles of type j by fj, 1 ' j 5 15.
Let Aii be the normalized fraction of vesicles of size class j that contain
i bound peptides, i.e.,
Nj
EAij= 1, (2)
i=O
in which Nj is the largest number of peptides that can bind to a vesicle of
size class j. The procedures for calculating the quantities Aii from binding
data have been described before (Nir et al., 1986; Bentz et al., 1988;
Parente et al., 1990; Nir et al., 1994). The expression for L(t) is given by
S Nj
L(t) = E > Z(M, t, i, j, C, D)Aijj§,
j=l i=M
(3)
in which Z(M,t,i,j,C,D) is the probability that at time t a vesicle of size class
j that contains i bound peptides will include an aggregate consisting ofM
or more peptides, and C and D are the rates of surface aggregation and
disaggregation, respectively. The function Z(M,t,i,j,C,D) is described in the
Appendix.
The final extents of leakage are obtained by setting t= m. Experimen-
tally, final extents of leakage were considered at t = 900 s. Because the
functions Ai, andfj are fixed quantities, the final extents of leakage depend
only on the value of M, the pore size, and the equilibrium constant for
two-dimensional aggregation,
Ks= CID. (4)
The parameters M and K. are determined from the final extents of
leakage for a wide range of lipid/peptide ratios.
RESULTS AND DISCUSSION
Our focus has been on the analysis of the extent of peptide-
induced leakage and elucidation of the mode of peptide
aggregation in the membrane. The leakage experiments
were conducted at lipid/peptide ratios that varied from
2600:1 to 25:1. First we verified that under these conditions
pardaxin is not able to induce vesicle aggregation or fusion
to a significant extent. A control experiment that applied a
fluorescence resonance energy transfer assay (Struck et al.,
1981) after lipid mixing was performed. At lipid/peptide
ratios of 221:1 and 84:1 we found that vesicle fusion did not
occur, because no membrane mixing, reflected by an in-
crease in fluorescence, was observed (results not shown).
Turbidity measurements at a lipid concentration similar to
that used in the leakage assay (32 ,uM) indicated that
peptide-induced vesicle aggregation did not occur at lipid/
peptide ratios of 138:1, 64:1, and 53:1 (data not shown).
Therefore, the observed peptide-induced leakage occurred
from each vesicle essentially independently of its interac-
tion with other vesicles.
Binding experiments
The analysis of the leakage results and the determination of
the pore size are based on knowledge of the amount of
peptide bound to the liposomes in the range of lipid/peptide
ratios used in the leakage experiments. These values are
necessary to calculate the elements of the distribution func-
tion Ai, in Eq. 2. Therefore, we measured the binding of the
peptide to vesicles utilizing the fluorophore NBD, as its
fluorescence intensity reflects the environment in which the
probe is located (Frey and Tamm, 1990; Rapaport and Shai,
1991). NBD-labeled pardaxin (0.1 ,uM), in buffer composed
of 150 mM NaCl and 10 mM HEPES (pH 7.4), was titrated
with PC/PS/Chol (4/4/1, w/w/w) vesicles, and the increases
in the fluorescence intensities due to peptide membrane
partition were recorded at 25°C and 43°C.
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A value for F,X, the fluorescence signal obtained when all
of the peptide is bound to lipid, was extrapolated from a
double-reciprocal plot of F (total peptide fluorescence) ver-
sus CL (total concentration of lipid), as previously described
(Schwarz et al., 1986). This value enabled us to determine
the fraction of membrane-bound peptide at each lipid con-
centration for both temperatures, and the results are shown
in Fig. 1. From the results it is evident that at each lipid-
to-peptide ratio, the elevated temperature facilitates the par-
titioning of higher amounts of peptide into the liposomal
membranes. We analyzed the data as a partition equilibrium
(for details see Rapaport and Shai, 1991) using the formula
Xb =Kpf,
where Xb is defined as the molar ratio of bound peptide per
60% of the total lipid, Kp corresponds to the partition
coefficient, and Cf represents the equilibrium concentration
of free peptide in the solution. The surface partition coef-
ficients of pardaxin were calculated to be 1.0 (±0.3) X 105
M-l and 3.4 (±0.3) X 105 M-1 at 250C and 43°C, respec-
tively.
According to a mechanism of graded release, the expected
value was 45% (Matsuzaki et al., 1993). Hence, we can
conclude that the leakage occurred essentially according to
an all-or-none mechanism, which is indicative of a leakage
mechanism by pore formation.
Fig. 2 shows the extents of calcein leakage from the
liposomes at 30°C and at 43°C 15 min after the addition of
pardaxin at lipid/peptide ratios ranging from 2600:1 to 25:1.
The presentation of the data as a function of bound peptide/
lipid ratios emphasizes the fact that for the same amount of
bound peptide, a greater leakage occurs at 30°C than at
43°C. We denote the leakage level attained after 15 min as
the "final extent," but unlike the leakage induced by other
peptides, e.g., GALA (Parente et al., 1990), the leakage
induced by pardaxin still proceeded after 15 min, although
at an extremely slow rate.
Analysis of final extents of leakage: pore
formation by reversible surface aggregation
Because, as t -* oo, Z becomes a function of Ks (see Eq. 3),
the final extent of leakage becomes
Final extents of leakage
The leakage of calcein was monitored by the dequenching
of its fluorescence due to its dilution. The mechanism of
leakage was determined at 43°C. When 64% leakage was
observed, the vesicle suspension was taken from the cuvette
and eluted through a gel filtration column. It was found that
whereas initially the fluorescence of the dye within the
vesicles was 90% quenched, the dye within the eluted
vesicles after the leakage experiments was 84% quenched.
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FIGURE 1 Effect of temperature on the binding of NBD-labeled
pardaxin to lipid vesicles. Peptide (0.1 j,M) was titrated with PC/PS/Chol
(4:4:1) small unilamellar vesicles, in buffer composed of 100 mM NaCl, 25
mM HEPES, pH 7.3, at either 43°C (0) or 25°C (M). The increase of
fluorescence intensity was monitored with the excitation at 460 nm and the
emission at 530 nm. The fraction of bound peptide was calculated as
described in the text.
s Nj
L0. = E Z(M, o,ij,j, Ks)Ai,j1
j=1 i=M
for reversible aggregation, whereas
s Nj
LO. = I EA>ijj
j=l i=M
(5)
(6)
for irreversible aggregation (Parente et al., 1990). Equation
6 reflects the assumption that when aggregation is irrevers-
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FIGURE 2 Calcein release induced by pardaxin as a function of bound
peptide/lipid molar ratio. Pardaxin at various amounts was added to vesi-
cles containing 60 mM encapsulted calcein at either 43°C (-) or 30°C (A).
The leakage of calcein after 15 min was monitored fluorometrically (see
text) and is plotted as a function of the bound peptide/lipid ratio. The bound
peptide was calculated according to the partition coefficients obtained from
the binding experiments.
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ible, all of the peptides within a membrane will eventually
be incorporated into a single aggregate, so that all vesicles
with at least M bound peptides will eventually leak.
We have compared the predictions of Eqs. 5 and 6 in an
attempt to explain the final extents of leakage as a function
of lipid/peptide ratio. Table 1 presents the experimental
values of the final extents of leakage for several lipid!
peptide ratios and the pore sizes, M, which were deduced
from them using Eq. 6. The table shows that when the
surface aggregation of pardaxin is assumed to be irrevers-
ible, the derived M values vary between -120 and several
thousand. In view of the large deduced values ofM and their
variability with lipid/peptide ratios, this model is unaccept-
able. Setting the rate of aggregate dissociation, D = 0
implies that KS = CID tends to infinity. The probability of
finding large surface aggregates of the peptide diminishes
with decreasing K. values. Consequently, a decrease in KS
corresponds to smaller deduced values ofM for each value
of the lipid/peptide ratio (see Eq. 5).
In Table 1, we present the values ofM deduced from Eq.
5 using different values of K, The best fit at 30°C is
obtained with KS = 0.002 and M = 6. The limits of the fit
were M = 6 ± 3, with corresponding K, values of 0.0002
forM = 3 and 0.005 forM = 9. The predicted final extents
of leakage for the values K. = 0.002 and M = 6 are also
presented and compared to the experimental values. To fit
the experimental values of the final extents of leakage at
43°C, we used the same value of M, but K. was set at 0.001.
The results in Table 1 indicate a very good fit of calculated
values to the experimental values of final extents. The
values of R2 were 0.94 and 0.98 at 30°C and 43°C, respec-
tively. The corresponding values of root mean square error
(RMSE) were 6.9% and 4.2%, i.e., within the estimated
experimental errors. The RMSE is given by
RMSE = I (Yi-Yci)2/(n-2) , (7)
in which Yi and Yci are experimental and calculated values
of percentage leakage and n is the number of data points.
Kinetics of calcein leakage
The experimental kinetics of calcein leakage from the lipo-
somes are shown in Fig. 3. The effect of temperature on the
kinetics of leakage is shown by comparing the results at
30°C (Fig. 3 A) with those at 43°C (Fig. 3 B) for the same
lipid/peptide ratio. It is evident that the kinetics of calcein
release is enhanced with the increase in temperature,
whereas the final extent is decreased with the increase in
temperature (Fig. 1).
TABLE I Final extents of leakage and minimum number of peptides for pore formation
Temp. Lipid:peptide Experimental
(OC) molar ratio* leak (%)t Calculated leak (%) M for different values of K,
M =6, K, = 0.002 KS = inf. KS = 0.02 KS = 0.002 KS = 0.0002
30 2210 0.0 0.5 119 20 8 3
737 3.5 5.9 279 18 6 3
442 16.5 13.0 376 16 6 3
221 24.5 27.9 680 19 6 3
147 28.5 38.4 942 21 7 3
111 50.5 46.1 954 16 6 2
74 49.0 56.5 1526 20 7 3
28 86.0 76.8 2267 13 4 2
M =6, Kr= 0.001 KS = inf. KS = 0.01 KS= 0.001 KS= 0.0001
43 2654 1 0 118 11 4 3
1380 2 1 216 14 5 3
1150 1 1 268 18 6 3
676 4 3 419 17 6 3
466 4 7 609 20 7 3
342 10 11 723 18 6 3
233 12 17 1036 20 7 3
171 27 24 1097 17 6 3
117 27 34 1598 20 7 3
114 37 34 1439 17 6 2
86 36 42 2052 20 7 3
59 47 52 2617 19 7 3
43 59 60 3055 18 6 2
30 64 68 3974 20 7 3
22 80 74 4388 15 5 2
The critical number of peptides required for pore formation, M, was calculated for each lipid/peptide ratio with different values of K. to fit the experimental
values of final extent. Using the best fit for M, M = 6, the experimental final extents are compared to a calculated value using Eq. 5.
*The experimental error is ±15%.
tThe experimental error is ±5%.
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FIGURE 3 Experimental kinetics of calcein release induced by pardaxin. Various amounts of pardaxin were added to vesicles containing 60 mM
encapsulted calcein at 30°C (A) or 43°C (B). The kinetics of the leakage were followed by monitoring the increase of the fluorescence intensity at 520 nm
and are plotted versus time. For each amount of added peptide the molar ratio of bound peptide/lipid was calculated, and the experimental kinetics are
plotted. Lipid/peptide molar ratios: O, 110; 0, 221 (A); A, 114 (B).
Reversibility of binding and surface aggregation
Our theoretical analysis supports a mechanism of calcein
leakage by pore formation after reversible surface aggrega-
tion of the peptide pardaxin. In the following, we present the
results of experiments that demonstrate that binding of the
peptide to PC/PS/Chol liposomes and its aggregation, both
within the membrane and in solution, are indeed reversible
processes.
In testing whether the binding and the surface aggrega-
tion of the peptide are reversible processes, we utilized a
fluorescein-labeled peptide. The fluorescence of the fluo-
rescein probe is self-quenched because of the close prox-
imity of other fluorophore molecules (Chen and Knutson,
1988). Therefore, the fluorescence intensity of the labeled
peptide can give information on its aggregation state. The
data presented in Fig. 4 (continuous line) revealed that the
labeled peptide (0.84 ,uM) tends to self-associate to a lim-
ited extent and in slow kinetics in buffer composed of 150
mM NaCl and 10 mM Tris (pH 7.4). However, upon addi-
tion of PC/PS/Chol LUV (40 ,uM), a dramatic decrease in
the fluorescence was observed, reflecting fast binding of the
peptide to the vesicles and self-quenching of the probes
because of their high local concentration in the membrane.
A further addition of vesicles to a final concentration of 381
,tM caused an increase in the fluorescence due to redistri-
bution of the peptide among all of the vesicles. When the
peptide was added in the presence of 79 ,uM lipid vesicles
(Fig. 4, dashed line), the fluorescence level was higher than
that observed in the presence of 40 ,uM, probably because of
a lower peptide concentration in the bilayer. The final level
after adding vesicles to a final concentration of 381 ,uM was
similar to that in the first case. For comparison, the peptide
was added initially to 381 ,tM lipid (dotted line), and the
resulting fluorescence level was higher than in the first two
cases. However, the fluorescence level in both cases (con-
tinuous and dashed lines), where a large amount of vesicles
was added after a small amount, continued to increase,
reflecting a slow process of redistribution of the peptide
molecules among the total liposome population. Addition of
detergent (Triton X-100), which solubilized the vesicles,
resulted in a sharp increase in the fluorescence intensity,
suggesting that the aggregated peptide was in the mem-
brane-bound state. These results suggest that the binding of
the peptide to the membrane is a reversible process.
To study the reversibility of the surface aggregation of
the peptide, the ability of native peptide to reverse the
self-quenching of labeled peptide was investigated. Indeed,
the fluorescence level increased when a native peptide (0.84
,uM) was added to 0.42 ,uM labeled peptide premixed with
40 ,uM vesicles (Fig. 5, continuous line). The concentra-
tions of the labeled peptide and the vesicles were such that
about 75% of dye leakage was observed (Fig. 3). A similar
fluorescence level was obtained when the native peptide
was first mixed with the vesicles and the labeled peptide
was added later. These results demonstrate that surface
aggregation of pardaxin is a dynamic and reversible process.
The results of Fig. 4 might suggest that the aggregation of
pardaxin in solution is also a reversible process. We have
tested this possibility directly by comparing the extents of
calcein leakage in two cases: in the first case the peptide is
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FIGURE 4 Reversible binding of fluorescein-labled pardaxin. The flu-
orescence intensity of the labeled peptide was monitored at 525 nm (slit 5
nm) with the excitation at 480 nm (slit 5 nm). The experiment was done in
a buffer composed of NaCl (150 mM) and Tris (10 mM), pH 7.4, and
LUVs composed of PC/PS/Chol 4/4/1 (wlw/w) were used. Labeled peptide
(0.84 ,AM) was added at the first time point to buffer ( ), to 381 ,uM
vesicles (. ), or to 79 ,uM vesicles (- - -). Vesicles (40 ,uM) were added
to the peptide solution at the second time point ( ). At the third time
point more lipids were added, at 302 ,uM (--- ) or 341 ,uM ( ); thus
the final lipid concentration in all cases was 381 ,AM. In the third case (.
Triton X-100 (0.1% v/v) was added at point 3.
added to a vesicle suspension, and in the second case the
order is reversed and the peptide is incubated for a few
minutes in solution before the vesicles are added. The
results in Fig. 6 indicate that the leakage levels obtained in
the two cases are similar, although with slightly different
kinetics. Assuming that the peptide is at least partially
aggregated in solution, and because the peptide is believed
to bind to vesicles in the monomeric form, these results
indicate reversibility of its aggregation in solution. Further-
more, in another experiment we diluted a solution of the
labeled peptide sixfold. If the aggregation in solution were
not reversible, then the dilution would not affect the state of
quenching of the fluorescence of the peptide. However, the
dilution resulted in about a twofold increase in the normal-
ized fluorescence (results not shown).
GENERAL DISCUSSION
We demonstrated that the mechanism of pardaxin-induced
leakage from PC/PS/Chol (4/4/1) LUVs is via pore forma-
tion utilizing reversible surface aggregation of the bound
peptide. The evidence of formation of pores consisting of at
leastM = 6 ± 3 peptides is based on 1) observation of final
FIGURE 5 Reversibility of surface aggregation of fluorescein-labeled
pardaxin. The fluorescence intensity of the labeled peptide was monitored
at 525 nm (slit 5 nm) with the excitation at 480 nm (slit 5 nm). The
experiment was done in a buffer composed of NaCl 150 mM and Tris 10
mM, pH 7.4, and LUVs composed of PC/PS/Chol 4/4/1 (w/w/w) were
used. Labeled peptide (0.42 ,uM) was added at the first time point to either
a suspension of lipid vesicles alone (40 ,uM) (- - -), or the same amount
of vesicles with pre-bound native peptide (0.84 ,uM) ( ). At the second
time point native peptide (0.84 ,uM) was added to the first solution (--
and Triton X-100 (0.1% v/v) was added to the second solution ( ).
extents of leakage, 2) the finding of an all-or-none mecha-
nism of leakage, 3) theoretical modeling that yields simu-
lations and predictions of the final extents of leakage for a
wide range of lipid/peptide ratios. The theoretical analysis
utilized detailed information on peptide binding and size
distribution of the liposomes, which is needed, according to
Eqs. 2 and 3. Knowledge of the size distribution of lipo-
somes is crucial, because the larger liposomes contain on
average more bound peptides and are more likely than small
liposomes to leak at high lipid/peptide ratios. In addition,
the leakage of a large liposome contributes more to the final
extent of leakage than does the leakage of a small one. This
pattern differs from the tendency of large liposomes to be
more stable and less permeable. Large liposomes also
yielded initially slower kinetics of Ca2+-induced leakage
than smaller liposomes (Bentz et al., 1983; Nir et al., 1983).
This predicted pattern of a larger extent of leakage from
larger liposomes was shown in a previous study with
pardaxin (Rapaport et al., 1994) as well as in studies em-
ploying various peptides such as GALA (Parente et al.,
1990) and the fusion peptide of HIV (Nieva et al., 1994). 4)
Earlier studies with many analogs of pardaxin using a
variety of biophysical and functional assays, which included
single-channel experiments (Shai et al., 1990, 1991; Shai,
1994), fluorescence studies (Rapaport and Shai, 1992), and
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FIGURE 6 Influence of order of addition of peptide and vesicles on the
extent of pardaxin-induced leakage. At the first time point 0.4 ,M pardaxin
(--- ) or 21 ,uM vesicles loaded with 60 mM calcein ( ) were added
to a buffer composed of NaCl (150 mM) and HEPES (10 mM), pH 7.4.
Then at the second time point vesicles were added to the peptide in solution
(- -), or pardaxin was added to the vesicle suspension ( ). The
fluorescence intensity at 520 nm was monitored and is plotted versus time.
energy calculation modeling (Lazarovici et al., 1992), sup-
port a channel formation mechanism as the mode of action
of pardaxin, rather than local disruption. In these channels
four is the minimum number of pardaxin molecules required
to form a conducting channel. It should also be noted that
the results clearly indicate that aggregates of peptides do
remain in the pool of reversible surface aggregates for times
longer than required for complete leakage of calcein (Fig.
5).
Using fluorescently labeled peptides, we have demon-
strated that pardaxin molecules tend to self-aggregate effi-
ciently within lipid vesicles (Rapaport and Shai, 1991,
1992). The realization that, unlike results with the synthetic
peptide GALA and the fusion peptide of HIV, the surface
aggregation of pardaxin is a reversible process was first
reached by analyzing the final extents of leakage. At 43°C,
if the possibility of reversible surface aggregation of
pardaxin were not considered, the calculations would yield
very large values of M, from 120 to 4400, depending on the
lipid/peptide ratio (see Table 1). Furthermore, we experi-
mentally demonstrated the reversibility of surface aggrega-
tion of pardaxin, observed as dequenching upon the addition
of unlabeled peptide to the fluorescein-labeled peptide (Fig.
5). This dequenching was due to exchange between labeled
and unlabeled peptides in surface aggregates. The results
also demonstrated reversibility of the aggregation of
pardaxin in solution and peptide exchange between vesicles.
This is different from the behavior observed with the fusion
peptide of HIV, where leakage and fusion were almost
completely abolished when the liposomes were added into
suspension 1 min after the peptide, and where exchange of
the peptide between vesicles was minimal (Nieva et al.,
1994). In our case, a large extent of leakage was still
observed, even when the liposomes were added to the buffer
several minutes after the peptide (Fig. 6).
It might appear that there is a discrepancy between the
observations of i) a limiting extent of leakage and ii) re-
versibility of surface aggregation of the peptide and its
exchange between vesicles. The answer is that the time it
takes for peptides to exchange between vesicles is several-
fold larger than the time required to reach an apparent final
extent of leakage. In fact, in several cases the final extents
were reached after 10 min within the experimental uncer-
tainty. In the cases examined after 25 min, the fraction
leaked was less than 1% above that of 5 min. Strictly
speaking, there is a very slow increase in leakage, even after
15 min, because of the exchange of peptides between ves-
icles. A comparison of Figs. 4 and 5 indicates that whereas
the incorporation of newly added peptide molecules into
existing surface aggregates takes about 1 min (Fig. 5), the
exchange of peptides from vesicles at a concentration of 40
,uM lipid to a large excess of added vesicles (341 ,iM) does
not terminate within 5 min.
We have attempted to apply calculations based on revers-
ible surface aggregation (Peled and Nir, unpublished re-
sults) to the results with GALA (Parente et al., 1990).
Despite the addition of one parameter, no improvement in
the fits to final extents was achieved. The leakage induced
by GALA from I-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine vesicles is well explained by assuming irrevers-
ibility of both binding and surface aggregation.
The effect of temperature on binding of pardaxin to
PC/PS/Chol liposomes and the subsequent leakage further
elucidate details of the leakage mechanism and the interac-
tions of the peptide with the liposomes. The results in Fig.
1 show enhanced binding with temperature. This can be
explained by a weakening of intermolecular interactions
between membrane constituents, which facilitates the pen-
etration of the peptide at elevated temperatures. In contrast,
the fraction of virus bound to cellular surfaces increases at
lower temperatures, indicating a different mechanism of
binding, namely binding to receptors rather than penetration
into the membrane (Duzgunes et al., 1992). The results in
Fig. 2 and Table 1 show that the extent of pardaxin-induced
leakage is enhanced by a reduction in temperature. This is in
contrast to the increase in permeability with temperature
(Papahadjopoulos et al., 1973; Szoka and Papahadjopoulos,
1980) and to the leakage of liposomes associated with
membrane fusion events. Our interpretation is that at lower
temperatures the extent of surface aggregation is enhanced,
as in aggregation phenomena in three dimensions.
The analysis of final extents of leakage yielded a larger
value for KS = CID (Tables 1) at 30°C than at 43°C. Hence,
the observed enhanced leakage at a lower temperature is a
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result of an increased fraction of vesicles that contain pores,
due to a larger extent of surface aggregation of pardaxin
molecules at lower temperatures. Thus we find for surface
aggregation of peptides a pattern of temperature dependence
similar to that previously found for particle aggregation at
equilibrium (Day et al., 1980; Nir et al., 1980; Bentz and
Nir, 1981; Nir et al., 1983; Peled et al., 1995). This phe-
nomenon has been explained by the increase of the constant
K = C/D with decreasing temperature, due to a steeper
decrease of the dissociation rate constant D than of the
forward rate constant of aggregation C.
The sequence of events that occurred in our experiments
when pardaxin was added to liposomes is summarized in
Fig. 7. These events include reversible aggregation of the
peptide in solution, reversible partitioning into the mem-
branes, reversible surface aggregation, and finally leakage.
When aggregation of liposomes occurs, pardaxin is also
capable of inducing membrane fusion (Rapaport et al.,
1993, 1994), but we have chosen conditions in which ves-
icle aggregation and fusion could be ignored, at least for the
larger lipid/peptide ratios used. The results described here
can help elucidate the mode of action of pardaxin in vivo.
Pardaxin is secreted from certain species of soles and is
postulated to be defensive, because it has shark-repelling
properties and is toxic to various organisms (Primor et al.,
1978). The biological activities of pardaxin are probably
due to its surface-active properties, as it was shown that it
interacts with biological and artificial lipid membranes
(Lazarovici et al., 1986; Shai et al., 1988). Furthermore,
pardaxin was found to form ion channels in artificial mem-
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brane systems (Shai et al., 1990), and its ability to trigger
exocytosis from cells was explained by the potential of the
peptide to form pores in the cell plasma membrane (Laz-
arovici and Lelkes, 1992). These accumulating data, to-
gether with the results of the present study, support a
hypothesis that at least part of the biological activities of
pardaxin are brought about by its ability to form pores in
lipid bilayers. Our present results further suggest that these
pores are formed because of reversible aggregation of
monomers within the membrane.
Animal antibacterial peptides serve as immune sub-
stances, and they are primary defense agents (Boman, 1991;
Zasloff, 1992), but the molecular events underlying their
activities are still not clear, and contradicting opinions exist
(Christensen et al., 1988; Steiner et al., 1988). We believe
that our combined theoretical and experimental approach
can be applied to other peptides to gain more insight into
their modes of action.
APPENDIX: PROBABILITY OF LEAKAGE
In this section we derive an expression for Z(M,t,i,j,C,D), the probability
that at time t a vesicle of size j containing i bound peptides includes an
aggregate of size greater than or equal to M. C and D are the rates of
surface aggregation and disaggregation of the peptide, respectively. The
derivation is based on those of Flory (1939) and Blatz and Tobolsky
(1945), which were applied to the polymerization of organic molecules.
They therefore assumed that, initially, all of the particles (monomers) are
identical and that each monomer has two free ends: A and B. A polymer-
ization reaction always involves an A end of one monomer and a B end of
another. The number of unreacted A ends is thus always equal to the
number of unreacted B ends and to the total number of particles (monomers
plus aggregates).
Following Flory (1939), we assume that all of the monomers can be laid
end to end and that each point of contact (link) is a potential bond. If we
define n(t) = concentration of particles (peptides in our case), monomers
+ aggregates; no = XO = total initial concentration of monomers; then:
Lipid Vesicle
no - n(t)
no
(A.1)
where p(t) is the ratio of reacted links (bonds) to the total number of links,
or the probability that a link has reacted.
Flory assumed that the reactivity of a link is independent of the number
of monomers in the aggregate. Therefore the probability that a monomer
chosen at random is part of an aggregate of size k is given by k . pk - '(1
- p)2, from which the relative concentration of aggregates of size k is
kk '(1
-p)2.
xo-
(A.2)
FIGURE 7 A schematic model for the processes involved in pore for-
mation by pardaxin. (1) Free peptides in solution; (2) peptide aggregates in
solution; (3) bound peptides in monomeric form; (4) aggregates of bound
peptide; (5) pore formed by an aggregate of bound peptides. Cb and Db are
the rates of binding and dissociation of peptides to and from the mem-
branes, respectively. C, and DV are the rates of aggregation and disaggre-
gation of peptides in solution, respectively. C is the rate of aggregation of
bound peptide in the membrane and D is the rate of disaggregation in the
membrane. Cm is the rate of morphological change of peptide aggregates to
pores. In the current treatment Cm was not considered.
The set of reactions represented by Eq. 1 were described by Blatz and
Tobolsky (1945) by the differential equations
dXk 1 0
dt - 2 I (kfXiXj- 2kb1,KY++j) (kfXiXk- 2kbXk+i),
i+j=k i=I
(A.3)
where kf is the rate of bimolecular addition and kb is the rate of unimo-
lecular splitting. Summation of the Eq. A.3 gives a single differential
equation in n(t):
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dn 1dn Ikfn2 + kb(no - n). (A.4)
The solution to Eqs. A.1 and A.4 is
p = ~ 1 -, (A.5)
K + K2-1.coth[ kfnotvK2 -1J
where
def kb
K= 1 + Xokf
A comparison of Eq. A.3 to similar equations (Bentz and Nir, 1981; Peled
et al., 1995) yields kf = 2C and kb = D/2, i.e.,
def D
K=l+4XC. (A.6)
At equilibrium, i.e., when t o, p is given by
1
pK +$ka- (A.7)
Because K in Eq. A.6 depends on CXO, i.e., on the size of the vesicles as
well as on the number of bound peptides, this parameter must be deter-
mined for each combination of i and j. In our calculations, we follow the
method used by Parente et al. (1990), i.e., we choose a reference vesicle of
radius 100 nm and measure XO as the surface density of peptides relative to
one peptide per reference area. Therefore, for a vesicle of typej with radius
rj and i bound peptides, Eq. A.6 becomes
def D 2.+(+ 4)2
K=l+4 c J1002+962 (A.8)
The value of C corresponds to the outer surface of a 100-nm-radius vesicle.
The probability that a monomer chosen at random is part of an aggre-
gate of size k is k * Xk/XO. Therefore, the probability that a monomer chosen
at random is part of an aggregate of size greater than or equal to M is
00
E k pk-10l -p)2. (A.9)
k=M
We assume that the probability of a vesicle leaking is equal to the above
and therefore,
Z(M, t, i,j, C, D) = pM-l(M-Mp + p), (A.10)
where p is given by Eq. A.5 for finite time, or by Eq. A.7 for t -X 00 and
K is given by Eq. A.8.
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